Search Results - "Tumas, Vitor"

Refine Results
  1. 1
  2. 2

    Recent advances in LC-MS/MS methods to determine endocannabinoids in biological samples: Application in neurodegenerative diseases by Marchioni, Camila, de Souza, Israel Donizeti, Acquaro, Vinicius Ricardo, de Souza Crippa, José Alexandre, Tumas, Vitor, Queiroz, Maria Eugênia Costa

    Published in Analytica chimica acta (31-12-2018)
    “…Endocannabinoids (ECs) are endogenous lipid-based retrograde neurotransmitters that bind to cannabinoid receptors [cannabinoid receptor 1 (CB1) and cannabinoid…”
    Get full text
    Journal Article
  3. 3

    The clinical diagnosis of Parkinson's disease by Munhoz, Renato P, Tumas, Vitor, Pedroso, José Luiz, Silveira-Moriyama, Laura

    Published in Arquivos de neuro-psiquiatria (01-06-2024)
    “…After more than 200 years since its initial description, the clinical diagnosis of Parkinson's disease (PD) remains an often-challenging endeavor, with broad…”
    Get full text
    Journal Article
  4. 4

    Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on Neuroinflammation by Santos-Lobato, Bruno L., Gardinassi, Luiz Gustavo, Bortolanza, Mariza, Peti, Ana Paula Ferranti, Pimentel, Ângela V., Faccioli, Lúcia Helena, Del-Bel, Elaine A., Tumas, Vitor

    Published in Molecular neurobiology (01-02-2022)
    “…The existence of few biomarkers and the lack of a better understanding of the pathophysiology of levodopa-induced dyskinesia (LID) in Parkinson’s disease (PD)…”
    Get full text
    Journal Article
  5. 5

    Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study by Santos-Lobato, Bruno Lopes, Brito, Manuelina Mariana Capellari Macruz, Pimentel, Ângela Vieira, Cavalcanti, Rômulo Torres Oliveira, Del-Bel, Elaine, Tumas, Vitor

    Published in Arquivos de neuro-psiquiatria (01-05-2023)
    “…Levodopa-induced dyskinesia (LID) is a common motor complication of levodopa therapy in patients with Parkinson's disease (PD). Doxycycline is a widely used…”
    Get full text
    Journal Article
  6. 6

    Movement disorders in hereditary spastic paraplegias by Pedroso, Jose Luiz, Vale, Thiago Cardoso, Freitas, Julian Letícia de, Araújo, Filipe Miranda Milagres, Meira, Alex Tiburtino, Neto, Pedro Braga, França, Marcondes C., Tumas, Vitor, Teive, Hélio A. G., Barsottini, Orlando G. P.

    Published in Arquivos de neuro-psiquiatria (01-11-2023)
    “…Abstract Background Hereditary or familial spastic paraplegias (SPG) comprise a group of genetically and phenotypically heterogeneous diseases characterized by…”
    Get full text
    Journal Article
  7. 7

    Global cognitive performance is associated with sleep efficiency measured by polysomnography in patients with Parkinson's disease by Sobreira, Emmanuelle S. T., Sobreira‐Neto, Manoel A., Pena‐Pereira, Márcio A., Chagas, Marcos H. N., Fernandes, Regina M. F., Eckeli, Alan L., Tumas, Vitor

    Published in Psychiatry and clinical neurosciences (01-05-2019)
    “…Aim Sleep disorders can be associated with an increased risk for cognitive decline in patients with Parkinson's disease (PD). The aim of this study was to…”
    Get full text
    Journal Article
  8. 8

    Time Perception of an Artwork's Manipulation Is Distorted by Patients With Parkinson's Disease by Motta, Márcia Regina, Tumas, Vitor, Bueno, José Lino Oliveira

    Published in Frontiers in integrative neuroscience (08-03-2019)
    “…In artwork appreciation situations, individuals often show altered time perception. We tested the hypothesis that Parkinson's disease (PD) patients present…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Effects of Touching Sculptures on the Artistic Appreciation of Collative Emotional/Perceptual Properties by Bueno, José Lino Oliveira, Motta, Márcia Regina, Tumas, Vitor

    “…Abstract The relationship between physical stimulus and perception is fundamental to understand aesthetic appreciation. This study aimed to examine how the…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson's disease by Santos-Lobato, Bruno Lopes, Schumacher-Schuh, Artur F, Rieder, Carlos R M, Hutz, Mara H, Borges, Vanderci, Ferraz, Henrique Ballalai, Mata, Ignacio F, Zabetian, Cyrus P, Tumas, Vitor

    Published in Arquivos de neuro-psiquiatria (01-04-2020)
    “…There are currently no methods to predict the development of levodopa-induced dyskinesia (LID), a frequent complication of Parkinson's disease (PD) treatment…”
    Get full text
    Journal Article
  13. 13

    Assessment of different regions of interest-based methods for [99mTc]Tc DAT-SPECT quantification using an anthropomorphic striatal phantom by Alexandre-Santos, Leonardo, Trevisan, Ana Carolina, Pitella, Felipe Arriva, Tumas, Vitor, Silvah, Jose Henrique, Kato, Mery, de Moraes, Eder Rezende, Wichert-Ana, Lauro

    Published in EJNMMI physics (28-12-2022)
    “…Background and aims Molecular imaging of the dopamine transporters (DAT) provides valuable information about neurodegenerative diseases, such as Parkinson’s…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Harbinger of storm: influence of Oliver Sacks on levodopa therapy in early 1970s by Santos-Lobato, Bruno Lopes Dos, Tumas, Vitor

    Published in Arquivos de neuro-psiquiatria (01-08-2016)
    “…Most known by his literary ability, the words of the neurologist Oliver Sacks (1933-2015) also had an impact on scientific community about the role of levodopa…”
    Get full text
    Journal Article
  20. 20